NewsBite

Biotech misses the mark

The budding biotech has endured one of its worst weeks in its history as the stock collapsed a record 32.7 per cent on Wednesday.

Pharmaxis (PXS)

The budding biotech has endured one of its worst weeks in its history as the stock collapsed a record 32.7 per cent on Wednesday on worries that its key drug Bronchitol would not be approved by US medical regulators.

Loading...

Read More

Latest In Companies

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/biotech-misses-the-mark-20100625-iva96